Clinical Trials
32 trialsNeoadjuvant Treatment For Locally Advanced Thymic Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
Ohio State University Comprehensive Cancer Center
Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma
Shanghai Chest Hospital
HEARTS Trial for Thoracic Cancers
University of Wisconsin, Madison
PECATI
MedSIR
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Georgetown University
Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
Memorial Sloan Kettering Cancer Center
Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma
The First Affiliated Hospital with Nanjing Medical University
IMMUNORARE5
Hospices Civils de Lyon
Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors
Shanghai Proton and Heavy Ion Center
Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
Sun Yat-sen University
RELEVENT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
Weill Medical College of Cornell University
The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.
Shanghai Zhongshan Hospital
SELECT
Georgetown University
ONC-2010-001
Istituto Clinico Humanitas
RESOUND
Istituto Clinico Humanitas
Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours
Shanghai Cancer Hospital, China
A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
Indiana University
Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor
Sun Yat-sen University
Style
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Jonsson Comprehensive Cancer Center
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Georgetown University
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Mayo Clinic
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Indiana University
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Stanford University
KOSMIC
Seoul National University Hospital
TET-SEL
Rigshospitalet, Denmark
Preoperative Treatment of Patients With High Risk Thymoma
Valley Health System
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
Indiana University
Paclitaxel and Cisplatin for Thymic Neoplasm
Korean Cancer Study Group
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
Roswell Park Cancer Institute